The Pharmaceutical Research & Development Unit of Shilpa Medicare Ltd situated at Modavalasa, Vizianagaram (Dt), Andhra Pradesh region has received US FDA Establishment Inspection Report (EIR) with intimation of closure of inspection on 08 Apr 2019.
This R&D site has undergone an inspection by the USFDA during 11 Feb 2019 to 13 Feb 2019, wherein we were issued a Form 483 with 1 (one) observation. Based on our responses and follow up actions, the USFDA has determined the inspection classification of this facility as Voluntary Action Initiated (VAI).
Shares of SHILPA MEDICARE LTD. was last trading in BSE at Rs.398.7 as compared to the previous close of Rs. 376.2. The total number of shares traded during the day was 8092 in over 838 trades.
The stock hit an intraday high of Rs. 414.75 and intraday low of 360.9. The net turnover during the day was Rs. 3141860.